OmniAb (OABI) Amortizatization of Intangibles (2022 - 2026)
OmniAb (OABI) reported Amortizatization of Intangibles of $6.0 million for Q1 2026, up 85.87% year-over-year from $3.2 million in Q1 2025, and up 2359.02% quarter-over-quarter from $244000.0 in Q4 2025.
OmniAb (OABI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
OmniAb (OABI) has 5 years of Amortizatization of Intangibles data on file, last reported at $6.0 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $6.0 million, up 85.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 11.55% YoY), and the FY2025 annual result was $858000.0, down 42.72% from the prior year.
- Amortizatization of Intangibles advanced to $6.0 million in Q1 2026 per OABI's latest filing, from $244000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $6.0 million in Q1 2026 and troughed at -$2.8 million in Q2 2025.
- A 5-year average of $854785.7 and a median of $499500.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 418.97% in 2025 and fell as far as 838.99% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $170000.0 in 2022, then soared by 364.71% to $790000.0 in 2023, then slumped by 73.04% to $213000.0 in 2024, then climbed by 14.55% to $244000.0 in 2025, then surged by 2359.02% to $6.0 million in 2026.
- Business Quant data shows OABI's Amortizatization of Intangibles at $6.0 million in Q1 2026, $244000.0 in Q4 2025, and $172000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Sep 30, 2025 | 172,000.00 |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 213,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Jun 30, 2024 | 377,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Mar 31, 2024 | 622,000.00 |
| Dec 31, 2023 | 790,000.00 |
| Dec 31, 2023 | 790,000.00 |